SCHEMBL21807360

SCHEMBL21807360

Cc1nc2cccc(Br)n2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.54
EGLN2 Q96KS0 1/20 0.47
CYP11B2 P19099 1/20 0.42
HPGD P15428 2/20 0.36
NUDT1 P36639 2/20 0.35
TP53 P04637 1/20 0.34
PDE10A Q9Y233 2/20 0.33
NPC1 O15118 1/20 0.33
HCRTR1 O43613 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
HAVCR2 Q8TDQ0 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3303841 0.79 AHR (0.58) AHRCYP11B2NUDT1PDE10A
SCHEMBL258972 0.79 EGLN2 (0.50) EGLN2CYP11B2PDE10ANPC1RAB9A
SCHEMBL13457590 0.78 AHR (0.56) AHRCYP11B2NUDT1
SCHEMBL20265119 0.77 AHR (0.47) AHREGLN2CYP11B2HPGDNUDT1
SCHEMBL28530395 0.76 AHR (0.54) AHRCYP11B2NUDT1
SCHEMBL45713 0.76 NUDT1 (0.56) AHREGLN2CYP11B2NUDT1PDE10A
SCHEMBL543601 0.76 EGLN2 (0.47) AHREGLN2CYP11B2NUDT1TP53
SCHEMBL16439318 0.76 AHR (0.50) AHREGLN2CYP11B2
SCHEMBL19659205 0.73 EGLN2 (0.45) EGLN2CYP11B2NUDT1TP53PDE10A
SCHEMBL19658704 0.73 EGLN2 (0.45) EGLN2CYP11B2NUDT1PDE10ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3852790-A1 INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X Forma Therapeutics, Inc. (US) 2021-07-28 EP disclosed
WO-2020061261-A1 INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X FORMA THERAPEUTICS, INC. (US) 2020-03-26 WO disclosed